Informing patient Study
Item
the patient was correctly informed about the study, its implementation, objectives, associated restrictions and patient rights
boolean
C0588446 (UMLS CUI [1,1])
C2603343 (UMLS CUI [1,2])
Informed Consent
Item
the patient must have given his/her informed and signed consent
boolean
C0021430 (UMLS CUI [1])
health insurance plan
Item
the patient must be insured or beneficiary of a health insurance plan
boolean
C0679933 (UMLS CUI [1])
Availability Follow-up
Item
the patient is available for 1 month of follow-up
boolean
C0470187 (UMLS CUI [1,1])
C1522577 (UMLS CUI [1,2])
Atrial Fibrillation | 12 lead ECG | electrocardiogram rhythm strip | Episode of Atrial Fibrillation
Item
the patient has non-valvular atrial fibrillation that was diagnosed within the last 3 months. documentation of atrial fibrillation by a 12-lead ecg, an ecg rhythm strip, atrial fibrillation episode lasting at least 30 seconds.
boolean
C0004238 (UMLS CUI [1])
C0430456 (UMLS CUI [2])
C2022160 (UMLS CUI [3])
C0332189 (UMLS CUI [4,1])
C0004238 (UMLS CUI [4,2])
Cerebrovascular accident Score | Congestive heart failure | Moderate left ventricular systolic dysfunction | Severe left ventricular systolic dysfunction | Systolic Pressure | Diabetes Mellitus | Ischemic stroke | EMBOLISM, SYSTEMIC ARTERIAL | Vascular Diseases | Myocardial Infarction | Arteriopathic disease | Age | Female
Item
the patient has a cha2-ds2-vasc score = 1, that is to say the presence of at least one of the following risk factors: (1) congestive heart failure or moderate to severe systolic dysfunction of the left ventricle; (2) history of systolic blood pressure> 160 mmhg; (3) diabetes; (4) history of ischemic stroke or systemic embolism; (5) vascular disease (myocardial infarction, arterial disease); (6) age > 65 years; (7) female.
boolean
C0038454 (UMLS CUI [1,1])
C0449820 (UMLS CUI [1,2])
C0018802 (UMLS CUI [2])
C3266752 (UMLS CUI [3])
C3266753 (UMLS CUI [4])
C0871470 (UMLS CUI [5])
C0011849 (UMLS CUI [6])
C0948008 (UMLS CUI [7])
C0149876 (UMLS CUI [8])
C0042373 (UMLS CUI [9])
C0027051 (UMLS CUI [10])
C0852949 (UMLS CUI [11])
C0001779 (UMLS CUI [12])
C0086287 (UMLS CUI [13])
rivaroxaban Xarelto | Hospitals, University
Item
the patient will start rivaroxaban (xarelto®) at the nîmes university hospital
boolean
C1739768 (UMLS CUI [1,1])
C3159309 (UMLS CUI [1,2])
C0020028 (UMLS CUI [2])
Study Subject Participation Status
Item
the patient is participating in another interventional study
boolean
C2348568 (UMLS CUI [1])
Study Subject Participation Status Past
Item
the patient has participated in another interventional study within the past three months
boolean
C2348568 (UMLS CUI [1,1])
C1444637 (UMLS CUI [1,2])
Exclusion Criteria Period
Item
the patient is in an exclusion period determined by a previous study
boolean
C0680251 (UMLS CUI [1,1])
C1948053 (UMLS CUI [1,2])
judicial aspects
Item
the patient is under judicial protection, under tutorship or curatorship
boolean
C0243116 (UMLS CUI [1])
Unwilling Informed Consent
Item
the patient refuses to sign the consent
boolean
C0558080 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Informing patient Unsuccessful
Item
it is impossible to correctly inform the patient
boolean
C0588446 (UMLS CUI [1,1])
C1272705 (UMLS CUI [1,2])
Pregnancy | Parturition | Breast Feeding
Item
the patient is pregnant, parturient, or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0005615 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
HEART-VALVE, MECHANICAL | Heart valve disease
Item
presence of a mechanical heart valve or valve disease
boolean
C0493527 (UMLS CUI [1])
C0018824 (UMLS CUI [2])
Other oral anticoagulants
Item
patient who recieved another new direct oral anticoagulant other than xarelto® in the previous three months
boolean
C0354604 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])